Statistics
Publications
1
Citations
11
H-Index
1
Active since
2022
Affiliations
Sichuan University(Current)
Zhengtan Xu is an author at Sichuan University specializing in molecular pharmacology, tumor progression, and ovarian cancer.
Publications per year
2022–2022
1
1
Isorhamnetin inhibits progression of ovarian cancer by targeting ESR1
Manman Wang, Zhengtan Xu, Qi Cai et al. · Annals of Translational Medicine · 2022 · 11 citations · Full text
Medicine, Oncology, Pharmacology +13
1–1 of 1